EMA adds severe allergies as side effect of Novavax COVID vaccine

[July 14, 2022]  (Reuters) - The European Medicines Agency on Thursday identified severe allergic reactions as potential side effects of Novavax Inc's COVID-19 vaccine.

Only 250,000 doses of Novavax's COVID vaccine, Nuvaxovid, have been administered in Europe so far, according to the European Centre for Disease Prevention and Control.

A vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/Illustration

(Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)

[© 2022 Thomson Reuters. All rights reserved.]  This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.